Log in to save to my catalogue

Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting...

Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2335179685

Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route

About this item

Full title

Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route

Publisher

England: Future Medicine Ltd

Journal title

Nanomedicine (London, England), 2020-01, Vol.15 (2), p.183-203

Language

English

Formats

Publication information

Publisher

England: Future Medicine Ltd

More information

Scope and Contents

Contents

In this study, the targeting of rifampicin (RIF)-loaded nanotransfersomes (NTs) incorporated in chitosan gel for leishmania-infected macrophages via the topical route was investigated.
NTs were prepared through a thin-film hydration process and incorporated into chitosan gel.
The mean particle size of the NTs was 190 nm, with 83% encapsulatio...

Alternative Titles

Full title

Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2335179685

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2335179685

Other Identifiers

ISSN

1743-5889

E-ISSN

1748-6963

DOI

10.2217/nnm-2019-0320

How to access this item